ADAP funding seen as insufficient; increases sought.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D017281:Cost of Illness; D016527:Drug Costs; D004359:Drug Therapy, Combination; D005380:Financing, Government; D017320:HIV Protease Inhibitors / Q000191:economics* / Q000627:therapeutic use; D006297:Health Services Accessibility; D006801:Humans; D008483:Medical Assistance; D013219:State Government; D014481:United States
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors